355 related articles for article (PubMed ID: 33508360)
1. Biological effects of formation of protein corona onto nanoparticles.
Mishra RK; Ahmad A; Vyawahare A; Alam P; Khan TH; Khan R
Int J Biol Macromol; 2021 Apr; 175():1-18. PubMed ID: 33508360
[TBL] [Abstract][Full Text] [Related]
2. Preservation of the soft protein corona in distinct flow allows identification of weakly bound proteins.
Weber C; Simon J; Mailänder V; Morsbach S; Landfester K
Acta Biomater; 2018 Aug; 76():217-224. PubMed ID: 29885856
[TBL] [Abstract][Full Text] [Related]
3. How Corona Formation Impacts Nanomaterials as Drug Carriers.
Gupta MN; Roy I
Mol Pharm; 2020 Mar; 17(3):725-737. PubMed ID: 31939673
[TBL] [Abstract][Full Text] [Related]
4. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
[TBL] [Abstract][Full Text] [Related]
5. In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.
Shang L; Nienhaus GU
Acc Chem Res; 2017 Feb; 50(2):387-395. PubMed ID: 28145686
[TBL] [Abstract][Full Text] [Related]
6. Amphiphilic dendrimers control protein binding and corona formation on liposome nanocarriers.
Wagner J; Dillenburger M; Simon J; Oberländer J; Landfester K; Mailänder V; Ng DYW; Müllen K; Weil T
Chem Commun (Camb); 2020 Aug; 56(61):8663-8666. PubMed ID: 32608398
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle-Protein Interaction: The Significance and Role of Protein Corona.
Ahsan SM; Rao CM; Ahmad MF
Adv Exp Med Biol; 2018; 1048():175-198. PubMed ID: 29453539
[TBL] [Abstract][Full Text] [Related]
8. Unveiling the pitfalls of the protein corona of polymeric drug nanocarriers.
Berrecoso G; Crecente-Campo J; Alonso MJ
Drug Deliv Transl Res; 2020 Jun; 10(3):730-750. PubMed ID: 32152965
[TBL] [Abstract][Full Text] [Related]
9. Concentration-dependent protein adsorption at the nano-bio interfaces of polymeric nanoparticles and serum proteins.
Zhang TX; Zhu GY; Lu BY; Zhang CL; Peng Q
Nanomedicine (Lond); 2017 Nov; 12(22):2757-2769. PubMed ID: 29017387
[TBL] [Abstract][Full Text] [Related]
10. Understanding the Lipid and Protein Corona Formation on Different Sized Polymeric Nanoparticles.
Lima T; Bernfur K; Vilanova M; Cedervall T
Sci Rep; 2020 Jan; 10(1):1129. PubMed ID: 31980686
[TBL] [Abstract][Full Text] [Related]
11. Beyond the protein corona - lipids matter for biological response of nanocarriers.
Müller J; Prozeller D; Ghazaryan A; Kokkinopoulou M; Mailänder V; Morsbach S; Landfester K
Acta Biomater; 2018 Apr; 71():420-431. PubMed ID: 29524674
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-protein complexes mimicking corona formation in ocular environment.
Jo DH; Kim JH; Son JG; Dan KS; Song SH; Lee TG; Kim JH
Biomaterials; 2016 Dec; 109():23-31. PubMed ID: 27648757
[TBL] [Abstract][Full Text] [Related]
13. Preparation of the protein corona: How washing shapes the proteome and influences cellular uptake of nanocarriers.
Brückner M; Simon J; Jiang S; Landfester K; Mailänder V
Acta Biomater; 2020 Sep; 114():333-342. PubMed ID: 32726673
[TBL] [Abstract][Full Text] [Related]
14. Plasma protein adsorption and biological identity of systemically administered nanoparticles.
Chen D; Ganesh S; Wang W; Amiji M
Nanomedicine (Lond); 2017 Sep; 12(17):2113-2135. PubMed ID: 28805542
[TBL] [Abstract][Full Text] [Related]
15. Cloaking nanoparticles with protein corona shield for targeted drug delivery.
Oh JY; Kim HS; Palanikumar L; Go EM; Jana B; Park SA; Kim HY; Kim K; Seo JK; Kwak SK; Kim C; Kang S; Ryu JH
Nat Commun; 2018 Oct; 9(1):4548. PubMed ID: 30382085
[TBL] [Abstract][Full Text] [Related]
16. Protein Corona Formation on Colloidal Polymeric Nanoparticles and Polymeric Nanogels: Impact on Cellular Uptake, Toxicity, Immunogenicity, and Drug Release Properties.
Obst K; Yealland G; Balzus B; Miceli E; Dimde M; Weise C; Eravci M; Bodmeier R; Haag R; Calderón M; Charbaji N; Hedtrich S
Biomacromolecules; 2017 Jun; 18(6):1762-1771. PubMed ID: 28511014
[TBL] [Abstract][Full Text] [Related]
17. Effect of nanoparticle size and PEGylation on the protein corona of PLGA nanoparticles.
Partikel K; Korte R; Stein NC; Mulac D; Herrmann FC; Humpf HU; Langer K
Eur J Pharm Biopharm; 2019 Aug; 141():70-80. PubMed ID: 31082511
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in silico protein corona formation evaluation of curcumin and capsaicin loaded-solid lipid nanoparticles.
Nishihira VSK; Rubim AM; Brondani M; Dos Santos JT; Pohl AR; Friedrich JF; de Lara JD; Nunes CM; Feksa LR; Simão E; de Almeida Vaucher R; Durruthy MG; Laporta LV; Rech VC
Toxicol In Vitro; 2019 Dec; 61():104598. PubMed ID: 31299314
[TBL] [Abstract][Full Text] [Related]
19. In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles.
Hadjidemetriou M; Al-Ahmady Z; Mazza M; Collins RF; Dawson K; Kostarelos K
ACS Nano; 2015 Aug; 9(8):8142-56. PubMed ID: 26135229
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticles in the Biological Context: Surface Morphology and Protein Corona Formation.
Richtering W; Alberg I; Zentel R
Small; 2020 Oct; 16(39):e2002162. PubMed ID: 32856393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]